Some thoughts on CS
1. Covid affect on numbers needs to be considered.
2. I have compared with Resmed who make breathing machines for sleep apnea. But CS more of a PPE manufacturer so caution warranted on comparison.
3. In short, CS makes an EBITA margin to sales of 38% versus Resmed at 31%. Very similar.
CS gross profit to sales is 75% versus Resmed at 60%.
As CS grows then reckon a lot will fall to bottom line as they get economies of scale with expenses.
4. Return on Assets is for CS at 40 % and compares with Resmed at 41%. Very similar. ( Have excluded goodwill from Resmed balance sheet for this calculation )
PRICING
In my view CS has been priced very cheaply relative to Resmed.
If CS lists at a Resmed type price then CS should trade at around $7. Very unlikely though.
CONCLUSION
CS is an excellent business being sold at a cheap price relative to Resmed.
Given size differences between two businesses reckon CS worth around $5 to $6 .A premium of about 15 to 40% on IPO price of $4.41.
- Forums
- IPOs
- CleanSpace IPO by Wilsons and Bells
CleanSpace IPO by Wilsons and Bells, page-4
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online